Finex logo
Finex Intelligence

Market Signal Briefing

Wire-ready dashboard awaiting your first source connection.

Last news saved at Mar 30, 13:54 1mo ago Cron last ran Mar 30, 13:54 1mo ago Awaiting first source
Switch language
91,488 Stories ingested Auto-fetched market intel nonstop.
0 Distinct tickers Add sources to start tracking symbols
Trending sources Waiting for fresh intel
Hot tickers Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-11-11 04:35 5mo ago
2025-11-10 21:47 5mo ago
Uniswap Token Soars Amid Fee Switch Proposal to ‘Align Incentives' cryptonews
UNI
In brief
Uniswap has proposed activating protocol fees and funding a perpetual UNI burn, including a one-time retroactive burn of about 100 million tokens.
The overhaul aims to channel the DEX’s sizable fee revenue to token holders, addressing a long-standing value gap.
New mechanisms, MEV discount auctions, ending front-end fees, and v4 “aggregator hooks, ”seek to deepen liquidity and expand revenue, according to the proposal.
The native token belonging to decentralized exchange Uniswap is soaring this week, outpacing major cryptocurrencies amid a slew of changes expected to boost revenue and shore up liquidity.

Unveiled on Monday, the "UNIfication" proposal from Uniswap Labs and the Uniswap Foundations aims to put the protocol's roughly $650 million in daily trading volume to work by activating protocol fees to fund a perpetual UNI token burn. 

A token burn permanently removes tokens from circulation, reducing supply and increasing scarcity, potentially lifting the value of the remaining tokens. According to the proposal, the aim "aligns incentives across the Uniswap ecosystem."

Roughly 100 million UNI tokens are expected to be burnt from the treasury retroactively, pegged from the time of the exchange’s inception. UNI is up 41.5% over the past 24 hours and a further 83% on the week, according to CoinGecko data.

“Uniswap is the largest and the original spot DEX since 2018, generating more than $1 billion in fees annually, but there has not been a mechanism to pass that value to token holders,” Peter Chung, head of research at quantitative trading firm Presto, told Decrypt. “This proposal, if implemented, will change that.”

Over the past month, Uniswap has accrued $222 million in fees, per DefiLlama data, bringing the protocol's annualized fees to over $2 billion. In total, the platform has generated cumulative fees of $5.4 billion, exceeding its total value locked of $5 billion.

Beyond the burn, the ambitious plan introduces several key mechanisms, including Protocol Fee Discount Auctions for MEV internalization and a refocus on core protocol growth by ending fees for Uniswap Labs' front-end interface, wallet, and API.

The proposal also seeks to launch “aggregator hooks,” aiming to turn Uniswap v4 into an onchain aggregator that collects fees on external liquidity. 

“This proposal comes as DeFi reaches an inflection point,” Uniswap founders Hayden Adams, Ken Ng, and Devin Walsh wrote in the proposal.

“Decentralized trading protocols are rivaling centralized platforms in performance and scale, tokens are going mainstream, and institutions are building on Uniswap and other DeFi protocols,” they added.

They also said a changing regulatory landscape under the Trump administration and the end of its legal troubles, in which it had previously been accused of promoting scam tokens and violating the Securities Act, had prepared the Uniswap community for its “next steps.”

“Labs will also accelerate growth through builder programs, grants, incentives, partnerships, M&A, venture, onboarding institutions, and exploring moonshot efforts to unlock new value for the Uniswap ecosystem,” the proposal reads.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.
2025-11-11 04:35 5mo ago
2025-11-10 22:00 5mo ago
Ethereum Approaches Critical Resistance — Bullish Breakout Or Trap In The Making? cryptonews
ETH
Ethereum is once again knocking on a major resistance level, sparking fresh excitement across the market. After a steady climb, ETH now faces a crucial test near the $3,700 mark, a zone that could determine whether bulls reclaim control or if another pullback is on the horizon Ethereum's Uptrend On The Line — Will Buyers Step In?
2025-11-11 04:35 5mo ago
2025-11-10 22:00 5mo ago
Solana's $2.85B revenue fuels its next ‘growth phase' – Here's how! cryptonews
SOL
Journalist

Posted: November 11, 2025

Key Takeaways
What’s driving Solana’s current growth?
Developer engagement and active protocols on Solana are creating a self-reinforcing loop of activity and revenue.

How significant is protocol revenue on SOL?
Daily milestones, such as ORE’s $1 million, highlight that protocol-level activity is a key metric fueling scalability and SOL’s growth phase.

Solana’s [SOL] multi-purpose ecosystem is once again in the spotlight.

Revenue momentum reshapes Solana’s L1 position
Recently, on X, Solana reposted a tweet highlighting the ORE [ORE] protocol hitting $1 million in daily revenue. Built on Solana, ORE reflects rising on-chain income and growing network utility.

Notably, this aligns with a recent 21Shares report.

As per the report, Solana averaged $240 million in monthly revenue. Peaks exceeded $600 million during intense activity. Overall, this totaled $2.85 billion for the year. 

Source: DeFiLlama

In short, the $1 million milestone shows ORE is now a key SOL player.

However, Pump.fun [PUMP] leads the pack. Over the past 30 days, PUMP has maintained its lead, generating $38 million in revenue, which underscores its dominant role in driving network activity on Solana.

From a broader perspective, these milestones highlight Solana’s evolution into a solid L1, thanks to its strategic upgrades.

However, does this also mean that SOL is entering a new phase, powered by steady revenue?

Developer engagement creates a growth loop on Solana
Just two years ago, Solana’s revenue was a fraction of what it is today. 

Back then, between October 2022 and September 2023, total network revenues stood at only $13 million. Fast forward to the 2024-2025 cycle, and this has soared to $2.85 billion, highlighting the rapid growth in activity.

In this context, the ORE milestone is just one piece of the puzzle. The bigger driver has been SOL’s developer community.

According to Chainspect, Solana leads all blockchains with 10,733 active developers.

Source: Chainspect

Simply put, high revenue on Solana is fueling a self-reinforcing loop.

As projects see more activity thanks to Solana’s strong fundamentals, more developers are building on the network. In turn, this incentivizes even more development and usage, pushing SOL into a new growth phase.

Against this backdrop, the protocol’s scalability is set to expand. Protocol revenue becomes a key metric, with ORE’s $1 million daily revenue showing how individual projects drive the network’s growth.

Ritika Gupta is a Financial Journalist and Geopolitical Analyst at AMBCrypto, specializing in the critical intersection of world politics, economic policy, and the cryptocurrency markets. Her analysis is informed by her distinguished background, which includes professional experience at major news network.
She holds a Bachelor's degree in Political Science and Psychology from Gargi College, University of Delhi. This academic training provides her with a sophisticated framework for dissecting complex issues such as international regulations, government fiscal policies, and the geopolitical forces that directly influence asset valuations.
At AMBCrypto, Ritika applies this expert lens to synthesize macroeconomic data and political developments, offering readers a deeper context for market movements. She excels at explaining not just what is happening in the market, but why it is happening. Her work is dedicated to providing strategic insights that empower readers to understand the complex relationship between global events and their digital assets.
2025-11-11 04:35 5mo ago
2025-11-10 22:00 5mo ago
Cardano Faces First ‘Governance Shutdown' — Hoskinson Responds cryptonews
ADA
Cardano's on-chain governance entered uncharted territory this weekend after the meme-mascot account HOSKY declared that the network's Constitutional Committee (CC) was “dropping below the required seven members,” calling it “our first official government shutdown.
2025-11-11 04:35 5mo ago
2025-11-10 22:08 5mo ago
Ethereum Poised for Breakout — Can ETH Finally Clear Crucial Resistance? cryptonews
ETH
Ethereum price started a recovery wave above $3,500. ETH is showing positive signs but faces hurdles near the $3,650 resistance.

Ethereum started a decent upward move above $3,420 and $3,500.
The price is trading above $3,550 and the 100-hourly Simple Moving Average.
There is a bullish trend line forming with support at $3,520 on the hourly chart of ETH/USD (data feed via Kraken).
The pair could continue to move up if it clears the $3,650 zone.

Ethereum Price Faces Resistance
Ethereum price managed to stay above $3,250 and started a recovery wave, like Bitcoin. ETH price was able to climb above the $3,350 and $3,420 resistance levels.

The bulls pushed the price above the 61.8% Fib retracement level of the downward move from the $3,920 swing high to the $3,058 low. The upward move was such that the price spiked to test the key hurdle at $3,650. Besides, there is a bullish trend line forming with support at $3,520 on the hourly chart of ETH/USD.

Ethereum price is now trading above $3,550 and the 100-hourly Simple Moving Average. If there is another recovery wave, the price could face resistance near the $3,650 level. The next key resistance is near the $3,710 level and the 76.4% Fib retracement level of the downward move from the $3,920 swing high to the $3,058 low.

Source: ETHUSD on TradingView.com
The first major resistance is near the $3,740 level. A clear move above the $3,740 resistance might send the price toward the $3,880 resistance. An upside break above the $3,880 region might call for more gains in the coming days. In the stated case, Ether could rise toward the $3,920 resistance zone or even $3,950 in the near term.

Another Pullback In ETH?
If Ethereum fails to clear the $3,650 resistance, it could start a fresh decline. Initial support on the downside is near the $3,540 level or the trend line. The first major support sits near the $3,485 zone.

A clear move below the $3,485 support might push the price toward the $3,360 support. Any more losses might send the price toward the $3,260 region in the near term. The next key support sits at $3,200 and $3,180.

Technical Indicators

Hourly MACD – The MACD for ETH/USD is losing momentum in the bullish zone.

Hourly RSI – The RSI for ETH/USD is now above the 50 zone.

Major Support Level – $3,485

Major Resistance Level – $3,650
2025-11-11 04:35 5mo ago
2025-11-10 22:30 5mo ago
Court Crushes $364M Bitcoin Claim Against US Government cryptonews
BTC
A federal appeals court has shut down one of the largest-ever bitcoin compensation claims, ruling that a convicted fraudster's $364 million demand against the U.S. government came far too late and lacked credible proof. Court Rejects $364 Million Bitcoin Claim The U.S.
2025-11-11 04:35 5mo ago
2025-11-10 22:45 5mo ago
XRP at $6 or Even $10? Analyst Says Not Before a Pullback to This Key Level cryptonews
XRP
XRP stole the show on Monday but what's next?
2025-11-11 04:35 5mo ago
2025-11-10 22:53 5mo ago
From Hero to Zero: How Bitdeer Lost 32% Despite Mining 1,109 Bitcoin cryptonews
BTC
Bitdeer shares surged 30% in October after announcing AI expansion and new data center plans.Q3 results revealed a $266.7M loss despite 174% revenue growth and 1,109 BTC mined.Shares fell nearly 20% as investors reacted to debt revaluation and infrastructure spending.Bitdeer Technologies’ shares fell nearly 32%, closing at $17.65, after reporting a $266 million quarterly loss. The drop followed a 30% rally on October 15, when the stock hit $25.90, fueled by investor optimism over AI and data center expansion plans.

The reversal highlights tension between growing revenue and Bitcoin production, and the impact of non-cash losses, capital expenditures, and large-scale infrastructure investment on profitability.

October Rally Fueled by AI and Infrastructure ExpansionOn October 15, Bitdeer (NASDAQ: BTDR) shares surged by more than 30% to $25.90 after announcing plans to expand into AI and high-performance computing (HPC) workloads. BTDR stock had fallen to $17.65 on Monday, marking a nearly 32% decline from its October peak.

Sponsored

Sponsored

Bitdeer stock price: Yahoo FinanceThe company said it will allocate 200 MW of energy to AI services. It targets annual revenues exceeding $2 billion by 2026. Bitdeer also added 241,000 mining machines across Norway, the US, and Asia. The firm mined 1,109 BTC during the quarter.

The expansion positioned Bitdeer alongside other miners such as MARA, IREN, and Core Scientific, which are increasingly integrating AI and HPC capabilities. Investors initially responded positively, seeing diversification into AI as a way to offset volatility in Bitcoin mining margins.

Quarterly Loss and Market ReactionBitdeer released unaudited Q3 2025 results, with revenue rising 174% year over year to $169.7 million. Adjusted EBITDA reached $43 million. The growth reflects higher Bitcoin production and efficiency gains from self-mining expansion.

“Q3 marked a quarter of strong execution and financial performance. Revenue, gross profit, and adjusted EBITDA improved significantly. Efficiency gains were driven by our self-mining expansion. Allocating 200 MW to AI cloud services could generate annualized revenue exceeding $2 billion by the end of 2026.” Matt Kong, Chief Business Officer at Bitdeer said.

However, the optimism reversed as the company posted a net loss of $266.7 million. This compares to a $50.1 million loss in the same quarter last year. It stemmed mainly from non-cash revaluation losses on convertible debt and elevated operational expenses.

Despite mining gains and expanded infrastructure, including the AI transition, which generated $1.8 million in revenue, investors focused on the impact of these paper losses. Following the report, Bitdeer shares dropped nearly 30% on the NASDAQ.

Continued AI Transition and Operational HighlightsIn October, Bitdeer continued its progress on its AI-focused infrastructure buildout. Operational data confirm increased production capacity and a growing hash rate, signaling the company’s intent to scale AI workloads while maintaining mining operations. However, Q3 results show financial pressures from capital-intensive expansion and market volatility. This weighed on short-term investor sentiment.

Disclaimer

In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
2025-11-11 04:35 5mo ago
2025-11-10 23:00 5mo ago
Solana leads institutional flows by $118M – Is altcoin season back? cryptonews
SOL
Journalist

Posted: November 11, 2025

Key Takeaways
What’s behind SOL inflows?
Recently launched U.S Spot SOL ETFs featuring staking could have been a catalyst. 

Is the altcoin season here?
According to the index reading, “YES.” However, most altcoins are yet to reverse their October losses. 

Solana [SOL] led the broader market recovery last week, with most bids coming from the institutional side. In fact, according to a CoinShares report, SOL topped the list with $118 million from institutional inflows, followed by XRP with $28.2 million. 

Surprisingly, Bitcoin [BTC] and Ethereum [ETH] led outflows, underscoring subtle rotation to other altcoins. 

Source: Coinshares

Given that the U.S Spot SOL ETF debuted last week with strong demand, the performance was not surprising.

Similarly, XRP ETFs are expected to launch this week and could have bolstered the institutional inflows. 

Hence, the question – Can the recovery lead to a broader surge in altcoins? Some altcoins, like NEAR, saw a strong rebound, erasing the losses incurred in October.

However, CryptoQuant data revealed that some players have been selling into the relief rally. 

Notably, the Altcoin Exchange Inflow Transaction Count, which tracks selling pressure on exchanges, spiked over the past few days. It illustrated a surge in altcoins moving into platforms for offloading. 

Source: CryptoQuant

Such moves are typical during historical altcoin market recoveries. 

Worth noting though that BTC dominance and USDT’s share, at press time, suggested that the rebound could extend if broader market sentiment improves. 

Interestingly, the BTC bounce to $106k was marked by a dip in BTC dominance from 60% to 59%. This meant that investors rushed to acquire recent, discounted altcoins. 

However, the sector can only maintain any momentum if the dominance of BTC and USDT continues to decline further. If so, it would illustrate a hike in buying power as investors and traders exchange their stablecoins for their favorite altcoin gems. 

Source: BTC vs USDT dominance, vs altcoins (TradingView)

And, the expected end to the U.S government shutdown could provide the needed catalyst to keep the upward momentum.

According to ETF Store’s Nate Geraci, reopening the government and the ETF market could fuel altcoins, especially XRP. 

Altcoin season index hits 100
From a performance perspective, Cardano [ADA] led the rebound among top crypto assets, with a 9% rally. XRP followed suit with an 8% jump, while ETH gained by 5%.  

Source: Altcoins performance, TradingView 

According to the aforementioned data, SOL may have led in institutional bids, but ADA and XRP dominated in terms of price chart gains.

Although the altcoin season index jumped to a strong momentum of “100,” several altcoins are yet to front a meaningful rebound. 

Source: Blockchain Centre
2025-11-11 04:35 5mo ago
2025-11-10 23:00 5mo ago
Could Shiba Inu Triple? Analyst Sees 200% Move Coming cryptonews
SHIB
According to technical commentary from analyst Javon Marks, Shiba Inu appears to have left a long accumulation zone and may be entering a fresh bullish phase. The token first showed a breakout in March 2024 and pushed up toward $0.000046. It reached about $0.00003328 on December 8, 2024, before falling hard in 2025.

Analyst Points To Accumulation Breakout
Marks highlights early bullish signals, including what he calls bullish divergences on the MACD that showed up earlier this year. Based on reports, he expects a move back into the $0.000032 area.

He even projects a potential 200% rally to that level from where the token trades now. From the current quoted price of $0.00001009, a push to $0.000080 would mean a rise of roughly 700% by his estimate. Those are large swings. Traders should note the math.

$SHIB (Shiba Inu) looks to be already broken out of a key accumulation and prices, which showed bull divergences early this year, can be preparing here for an ~200% move to test a resistance in the $0.000032s again. pic.twitter.com/Xw104EUT75

— JAVON⚡️MARKS (@JavonTM1) November 9, 2025

Derivatives Activity Shows Traders Positioning For A Move
Derivatives data adds another dimension. Reports show about $76 million in open interest tied to Shiba Inu contracts. Open interest jumped 15% over the weekend, and exchanges recorded 7.38 trillion tokens as outstanding futures exposure.

Gate.io accounted for 47% of that total, which equals about $36 million on that platform alone. On a day of rising bets, SHIB hit a high of $0.00001032.

Source: Coinglass
Volatility Has Been Extreme
SHIB’s path since December 2024 has been bumpy. After peaking above $0.00003 in late 2024, the token plunged to roughly $0.0000075 during the flash crash on October 10, 2025. It later recovered to about $0.00001003. Rapid moves like these show both the risk and the chance for big short-term gains. Positions in futures can make price swings bigger.

SHIB market cap currently at $5.91 billion. Chart: TradingView
What The Signals Might Mean For Traders
According to the chart reading, breaking past $0.000032 would open a clear resistance band and could attract more buyers. Some market players will treat that level as a key test. Others will watch open interest and exchange concentration for signs of overstretch. Moves driven by sentiment and leverage can reverse quickly. Gains may be fast. Losses can be fast too.

Based on reports and the analyst’s posts, momentum appears to be building. But this is a trader-led setup more than a proof of long-term value. Technical signals, heavy derivatives exposure, and past wild swings all matter.

Investors and traders should weigh the numbers: $0.000045, $0.00003329, $0.000032, $0.00001003, $0.0000075, $76 million, 15%, 7.38 trillion, and 47.13% are all part of the story.

Featured image from Unsplash, chart from TradingView
2025-11-11 04:35 5mo ago
2025-11-10 23:03 5mo ago
‘Cryptoqueen' facing sentencing over $6.5B Bitcoin stash cryptonews
BTC
The sentencing highlights how UK authorities are intensifying efforts to combat global fraud and money laundering in digital asset markets.

Photo: Kanchanara

Key Takeaways

Zhimin Qian, dubbed 'Cryptoqueen,' faces sentencing in the UK for her role in laundering $6.5 billion via Bitcoin.
The scam involved defrauding victims in China and using the illicit gains to buy luxury property in London.

A Chinese businesswoman known as the “Cryptoqueen” is facing sentencing in a UK court over her role in a Bitcoin money laundering scheme that involved defrauding victims in China and purchasing luxury London property.

Authorities seized 61,000 BTC in connection with the case, with the reported value hitting $6.5 billion at current market rates.

Zhimin Qian, who earned the nickname “Goddess of Wealth” for her lavish lifestyle, was convicted in connection with one of the largest cryptocurrency seizures in UK history. The case centers on proceeds laundered through high-end London real estate after victims were defrauded in China.

UK police conducted the major cryptocurrency seizure as part of their investigation into the international money laundering operation. Qian now faces a lengthy prison sentence following her conviction in the multibillion-dollar scam.

The sentencing marks a significant milestone in UK authorities’ efforts to crack down on crypto-related financial crimes involving international fraud schemes.

Disclaimer
2025-11-11 04:35 5mo ago
2025-11-10 23:13 5mo ago
Bitcoin Price Prediction: BTC Targets $111K as Nasdaq, Cboe, and U.S. Policy Shifts Ignite Market Optimism cryptonews
BTC
Bitcoin consolidates near $106K as Nasdaq and Cboe enter crypto—Bitcoin price prediction points to $111K breakout soon.
2025-11-11 04:35 5mo ago
2025-11-10 23:18 5mo ago
XRP Price Resumes Uptrend Amid Renewed Market Optimism and Whale Activity cryptonews
XRP
XRP price started a decent increase above $2.420. The price is now consolidating and might aim for more gains above the $2.580 level.

XRP price stayed above $2.40 and started a decent increase.
The price is now trading above $2.50 and the 100-hourly Simple Moving Average.
There is a short-term contracting triangle forming with resistance at $2.256 on the hourly chart of the XRP/USD pair (data source from Kraken).
The pair could continue to move up if it clears $2.580.

XRP Price Gains Traction
XRP price started a decent upward move above $2.320 and $2.350, like Bitcoin and Ethereum. The price gained pace for a clear move above the $2.420 resistance.

The pair even surpassed the $2.50 barrier. A high was formed at $2.580 and the price started a consolidation phase above the 23.6% Fib retracement level of the upward move from the $2.240 swing low to the $2.580 high. Besides, there is a short-term contracting triangle forming with resistance at $2.256 on the hourly chart of the XRP/USD pair.

The price is now trading above $2.50 and the 100-hourly Simple Moving Average. If there is a fresh upward move, the price might face resistance near the $2.560 level. The first major resistance is near the $2.580 level, above which the price could rise and test $2.550.

Source: XRPUSD on TradingView.com
A clear move above the $2.650 resistance might send the price toward the $2.7320 resistance. Any more gains might send the price toward the $2.7680 resistance. The next major hurdle for the bulls might be near $2.80.

Another Decline?
If XRP fails to clear the $2.580 resistance zone, it could start a fresh decline. Initial support on the downside is near the $2.50 level. The next major support is near the $2.420 level or the 50% Fib retracement level of the upward move from the $2.240 swing low to the $2.580 high.

If there is a downside break and a close below the $2.420 level, the price might continue to decline toward $2.350. The next major support sits near the $2.320 zone, below which the price could continue lower toward $2.250.

Technical Indicators

Hourly MACD – The MACD for XRP/USD is now gaining pace in the bullish zone.

Hourly RSI (Relative Strength Index) – The RSI for XRP/USD is now above the 50 level.

Major Support Levels – $2.50 and $2.420.

Major Resistance Levels – $2.560 and $2.580.
2025-11-11 04:35 5mo ago
2025-11-10 23:29 5mo ago
Crypto Funds Bleed $1.17B After October Liquidity Shock – Except SOL, XRP cryptonews
SOL XRP
Solana and select altcoins appear to have completely ignored the carnage.

Digital asset funds experienced another difficult week as investors withdrew $1.17 billion. This was the second week in a row of steep outflows. Confidence remains fragile after the October 10th liquidity shock, and macro uncertainty over the Fed’s December policy decision continues to weigh on positioning. CoinShares found that ETP trading volumes, however, stayed strong at roughly $43 billion.

On Thursday, flows briefly improved as headlines suggested movement toward averting the US government shutdown. But that brief window of optimism vanished quickly. By Friday, negative sentiment returned, and capital exited again as concerns re-emerged and markets priced in continued policy and fiscal uncertainty. Interestingly, altcoins have managed to largely defy the trend.

Altcoins Flip the Script
According to the latest edition of ‘Digital Asset Fund Flows Weekly Report,’ institutional capital moved sharply away from Bitcoin last week, as BTC-linked products recorded $932 million in net outflows. Short Bitcoin ETPs, however, drew renewed interest, pulling in $11.8 million and marking their highest weekly inflow since May 2025. Ethereum also suffered as it saw $438 million in outflows.

But interest in several altcoins remained positive. Solana again led with a significant $118 million in inflows and contributed to a massive $2.1 billion accumulated across the last nine weeks. Next up was XRP, which secured $28.2 million in fresh inflows, followed closely by Hedera with $26.8 million. Hyperliquid saw $4.2 million, and Litecoin managed $1.9 million. Multi-asset funds attracted more than $12 million. On the other hand, Sui and Cardano shed $3.8 million and $0.1 million.

Data continues to show a sharp regional imbalance. The US remains the most heavily impacted, bleeding $1.22 billion in outflows. Hong Kong was next with $24.5 million out, and Sweden lost $18 million during the same period. Meanwhile, Canada and Australia also reported smaller outflows of $7.6 million and $1.1 million.

Investor appetite grew in parts of Europe and Latin America. Germany posted $41.3 million in inflows and Switzerland captured $49.7 million, while Brazil registered fresh inflows of $12 million for the week.

Relief Rally Faces Hard Ceiling
The Senate’s progress on a funding deal boosted risk sentiment and lifted Bitcoin back above $106,000 after several failed breaks below $100,000. QCP Capital noted that this rebound is occurring despite ongoing spot ETF outflows and continued selling from long-term holders. Options flows remain split as buyers position for upside into December 2025, while others sell calls at higher strikes.

You may also like:

Bitcoin’s Taproot Supply Falls 3% Since 2024 as Quantum Risk Fears Rise

XRP ETF Watch: DTCC Listing Signals Possible 1933 Act Launch This Week

Rising Liquidity Pushes Bitcoin Into Bullish Consolidation

The firm said that OG wallet distributions resemble past events like Silk Road and Mt. Gox, and history shows markets can absorb such supply. QCP expects Bitcoin to stay range-bound for now, and says any move above $118,000 is likely to trigger more OG selling.

Tags:
2025-11-11 04:35 5mo ago
2025-11-10 23:30 5mo ago
Just In: U.S. Senate Passes Bill to Reopen Government as Bitcoin Breaks $106,000 cryptonews
BTC
In a surprise late-night move, the U.S. Senate has passed the amended appropriations bill to reopen the government after the longest shutdown in American history,  lasting 40 days. As reported by Eleanor Terrett, the bill now heads to the House for approval, where a final vote is expected within hours.

Lawmakers, eager to wrap up before the weekend, moved faster than anticipated. One source familiar with the negotiations summed it up: “I thought they wouldn’t be done until later tonight, but they sped through that. They want out of this town.”

🚨JUST IN: The Senate has passed the amended appropriations bill to reopen the government.

The bill now heads to the House and the Senate will be out for the rest of the week.

As one source of mine put it: “I thought they wouldn’t be done until later tonight but they sped…

— Eleanor Terrett (@EleanorTerrett) November 11, 2025 With the Senate now adjourned for the rest of the week, attention shifts to the House, which is expected to follow suit and pass the bill. If all goes as planned, federal operations could restart as early as tomorrow.

Bitcoin Reacts InstantlyNews of the deal triggered an immediate reaction in the crypto market. Bitcoin surged past $106,000, marking its highest level in nearly a week. Ethereum followed with a decent jump, and XRP climbed more than 2%.

The shutdown had frozen parts of the economy, delayed regulatory actions, and fueled risk aversion across global markets.

A Familiar PatternHistorically, government reopenings have coincided with strong bullish sentiment in crypto. The last major shutdown resolution, in early 2020, preceded a broad rally across risk assets — though external factors like the pandemic later disrupted that trend.

With Washington back to work and the Federal Reserve signaling caution on rate hikes, experts are betting that risk appetite could return. Bitcoin holding above the $100,000 support zone is also seen as a bullish sign.

A reopened government would restore funding for key agencies, including the SEC, which plays a crucial role in pending crypto-related decisions such as ETF approvals. The resumption of normal operations could therefore have ripple effects across digital asset markets in the coming weeks.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2025-11-11 03:35 5mo ago
2025-11-10 21:15 5mo ago
1 Under-the-Radar AI Stock That Looks Like a Screaming Buy Right Now stocknewsapi
AMPL
Amplitude's comeback may have just begun.

Three years after OpenAI launched ChatGPT, sparking a surge in semiconductor stocks like Nvidia, software stocks now seem to reap the benefits.

After all, hardware exists to run software, and there's no point in the billion-dollar data center build-outs if there isn't software available to take advantage of the hardware. In other words, the massive build-out implies a big wave of demand for artificial intelligence (AI) software as well.

A number of software-as-a-service (SaaS) stocks have rolled out AI products in recent months, showing the industry could be at a tipping point.

One of them is Amplitude (AMPL +7.19%), the digital product analytics company that recently launched a new AI platform featuring AI agents and other tools to help businesses more easily gain insights into their data and make improvements to their products.

The new AI launch already seems to be paying off for Amplitude as the company just reported its fastest revenue growth in more than two years, showing its momentum is accelerating after revenue growth bottomed last year.

Amplitude reported 18% revenue growth in the third quarter to $88.6 million, well ahead of the consensus at $86.3 million. On the bottom line, adjusted earnings per share (EPS) rose from $0.02 to $0.03, ahead of the consensus at $0.01.

Additionally, remaining performance obligations (RPO) jumped 37% to $391.9 million, showing that its customers are booking longer-term contracts as Amplitude's execution gets better and customers get more comfortable with it.

Guidance was also strong, calling for $89 million to $91 million, up 15% from the quarter a year ago, and adjusted EPS of $0.04 to $0.05. However, the most impressive part of the quarter is Amplitude's rollout of its AI platform.

Image source: Getty Images.

What Amplitude is doing with AI
After adding the guides and surveys feature, Amplitude has finished building out its core platform, and it's added several AI features in recent months.

The most important of those appears to be its Model Context Protocol (MCP), a server that connects AI assistants to the Amplitude platform, allowing its customers to use AI search or query to find data and get answers to the problems they're trying to solve, like learning how their customers typically move through the onboarding funnel.

CEO Spenser Skates said in an interview with The Motley Fool that MCP is the No.1 most requested feature from customers, adding, "We have tons of customers using it already. It expands access to Amplitude dramatically. It's fantastic."

Additionally, it launched AI Visibility, a free tool that anyone can use that is essentially search engine optimization (SEO) for large language models (LLMs), meaning that a user can search a company or brand and see how its performing in AI searches on chatbots like ChatGPT and Claude.

Finally, the company is also launching AI Feedback, which connects to feedback sources like Zendesk, tickets, online reviews, and social media, aggregates the feedback, and summarizes it.

Today's Change

(

7.19

%) $

0.72

Current Price

$

10.73

Is this a breakout moment for Amplitude?
According to Skates, customers are eager for exactly the kind of tools that Amplitude is rolling out. He said, "They are so hungry for this and they don't necessarily know what it is they want, but they want this to be better," referring to the analytics experience.

The opportunity here is massive, and Amplitude is still a small company in the software and analytics world, competing against behemoths like Alphabet's Google Analytics and Adobe Analytics. It's on track for $340.8 million to $342.8 million. Its market cap is just $1.3 billion, meaning the stock trades at a very affordable price-to-sales ratio (P/S) of just 4.

If its AI platform gains traction with its customers and its revenue growth accelerates, the stock could move a lot higher from here.
2025-11-11 03:35 5mo ago
2025-11-10 21:35 5mo ago
KBR DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages KBR, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action First Filed by the Firm - KBR stocknewsapi
KBR
November 10, 2025 9:35 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased KBR securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the KBR class action, go to https://rosenlegal.com/submit-form/?case_id=42136 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) despite the knowledge that the U.S. Department of Defense's Transportation Command (TRANSCOM) had, for months, had material concerns with HomeSafe's ability to fulfill the Global Household Goods Contract, defendants claimed that the partnership was without issue, and would ramp up in future quarters; and (2) as a result, defendants' statements about KBR's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the KBR class action, go to https://rosenlegal.com/submit-form/?case_id=42136 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273876
2025-11-11 03:35 5mo ago
2025-11-10 21:41 5mo ago
OFX Group Limited (OZFRY) Q2 2026 Earnings Call Transcript stocknewsapi
OZFRY
OFX Group Limited (OTCPK:OZFRY) Q2 2026 Earnings Call November 10, 2025 6:00 PM EST

Company Participants

John Malcolm - CEO, MD & Executive Director
Selena Verth - Chief Financial Officer

Conference Call Participants

Michael Trott - MST Financial Services Pty Limited, Research Division
Cameron Halkett - Canaccord Genuity Corp., Research Division
Olivier Coulon - E&P, Research Division

Presentation

Operator

Thank you for standing by, and welcome to the OFX Group Limited FY '26 Half Year Results. [Operator Instructions] I would now like to hand the conference over to Mr. Skander Malcolm, CEO and Managing Director. Please go ahead.

John Malcolm
CEO, MD & Executive Director

Thank you, Kaley, and thank you, everyone, for joining the call. As Kaley mentioned, I'm joined by Selena Verth, our Chief Financial Officer; and Matt Gregorowski from Sodali & Co., who leads our Investor Relations program. Selena and I will take you through the pages, and then there will be time for Q&A. The presentation will cover 6 sections: our mission, performance update, the 2.0 transition, our financials, the strategy execution and our outlook.

And then we'll have time for Q&A. So let's move to Slide 4 in the pack. And I want to start the presentation by being focused on our mission, which is simpler financial operations, helping businesses thrive globally. I start here because we must be very clear with our investors, our employees and our clients about what we're trying to do.

It may sound obvious, but it matters a great deal as we navigate the transition from a company that did one job very well for both corporate and consumer clients, which was making cross-border payments to becoming a company that does several jobs very well for our corporate clients to make their lives simpler and in turn, help them thrive. We've laid out this strategy

Recommended For You
2025-11-11 03:35 5mo ago
2025-11-10 21:43 5mo ago
The RealReal Reports Record GMV as Luxury Resale Demand Surges stocknewsapi
REAL
By

PYMNTS
 | 
November 10, 2025

 | 

The RealReal reported third-quarter results on Monday (Nov. 10) showing stronger sales and improved efficiency as the luxury resale market continues to attract cost-conscious consumers.

Gross merchandise value (GMV) increased 20% to $520 million compared to the same period in 2024, and revenue rose 17% to $174 million, prompting the company to raise its full-year GMV guidance to more than $2.1 billion.

Resale Moves Into the Mainstream
“Our strong third-quarter results and our full-year outlook for GMV of over $2 billion are a testament to our long-term strategy, which has solidified our position as the market leader in luxury resale,” Chief Executive Officer Rati Saha Levesque said. “We are changing the way people shop, making resale a primary option.”

She noted that Vogue used search data from The RealReal during the fall fashion season to gauge brand momentum, underscoring how the platform’s analytics now inform the broader luxury market.

The company’s internal report found fine jewelry as its fastest-growing category, first-time watch buyers up 46%, and searches for wedding dresses rising 247% from a year earlier. Handbag searches for fair-condition items grew 32%, reflecting a broader shift toward practicality and value retention.

Economic conditions continue to shape consumer behavior. A PYMNTS Intelligence study found that nearly 7 in 10 Americans live paycheck to paycheck, and 1 in 4 struggled to pay bills in recent months. Another PYMNTS study found that nearly half of U.S. shoppers now buy secondhand as frequently as they do new, signaling that resale has become part of regular purchasing behavior rather than a niche choice.

Advertisement: Scroll to Continue

For The RealReal, that normalization of the secondary market is expanding both supply and demand at once as shoppers sell to unlock value and buy to stretch spending power.

Operations and Data-Driven Supply
The company said its growth strategy focuses on supply quality and operational discipline. A revised compensation plan emphasizing value over volume lifted average supply value per luxury manager by 12%. The “Smart Sales” system, an internal analytics tool, and an AI-based “Smart Prospecting Engine” helped improve lead targeting and consignor conversion.

The RealReal’s AI-enabled intake system, Athena, handled 27% of all items during the quarter and is expected to reach 40% by year end. The system automates authentication and listing while shortening processing times from 14 days toward a goal of seven. Chief Financial Officer Ajay Gopal said Athena remains a “key contributor to cost leverage across operations.”

The company operates 18 stores nationwide and plans to add one to three per year. About 25% of new consignors come through retail locations, where in-house specialists authenticate and appraise inventory.

What Else Stood Out

Flywheelers, users who both buy and consign, are two to three times more valuable than single-side participants and drive higher transaction frequency and long-term loyalty.
Executives said that its AI-driven pricing algorithm continues to expand coverage across product categories, capturing higher realized prices for sellers and improving sell-through rates.
More than half of The RealReal’s customers are millennials or Gen Z, a cohort the company said is driving long-term engagement as resale becomes part of their standard purchase cycle.

The RealReal’s high-value pop-up events in retail locations, such as Newport Beach, California, and Tysons Corner, Virginia, generated more than $2.6 million in supply over a few days, signaling strong engagement with luxury consignors.

By the Numbers
Gross profit rose 16% to $129 million, supported by higher-value sales and automation gains. Consignment margins improved to 89%, and direct-sales margins rose to 21%. Operating expenses declined 6% as a share of revenue, reflecting continued cost discipline. The company ended the quarter with $123 million in cash and has reduced its debt by $86 million since early 2024.

For the fourth quarter, The RealReal expects GMV between $585 million and $595 million, up about 17%, and revenue between $188 million and $191 million, up roughly 16%. Management said efficiency improvements and sustained consumer demand for secondhand luxury are expected to support steady growth into 2026.
2025-11-11 03:35 5mo ago
2025-11-10 21:45 5mo ago
3 Beaten-Down Stocks That Haven't Been This Cheap in Over 5 Years stocknewsapi
KMB LULU TGT
These stocks are down between 20% and 57% this year.

If you're a bargain hunter and want to buy stocks that are dirt cheap, you're likely going to need to take on some risk. Struggling stocks are usually cheap for a reason. The key thing is to evaluate what that risk is, the likelihood that it can recover, and how long a turnaround may take.

Three stocks that are undesirable these days and have fallen to around their five-year lows are big names Lululemon Athletica (LULU +2.58%), Target (TGT 0.50%), and Kimberly-Clark (KMB 0.73%). Here's what you need to know about them before deciding whether or not to buckle down and take a chance on these stocks.

Image source: Getty Images.

1. Lululemon Athletica
Tariffs and a slowdown in discretionary spending are the big worries about Lululemon's stock these days. Although the apparel company has a solid brand that is popular with young people, when prices are too high and economic conditions too dire, sales are inevitably going to suffer.

This year, Lululemon's stock has plummeted an incredible 58%. The last time it was around these levels was back in March 2020. It's now trading at a price-to-earnings (P/E) multiple of 11, which seems cheap. But the problem is if the business' financials deteriorate, that multiple will climb higher, thus, that modest valuation is of little comfort these days.

Today's Change

(

2.58

%) $

4.28

Current Price

$

170.41

The company's comparable sales growth was just 1% in its most recent quarter, which ended on Aug. 3. I think there's potential for Lululemon to recover but a lot is going to depend on the strength of the economy. Its brand power could be what helps it bounce back, but I would expect that it may take at least a year or two before it happens. Lululemon is down big this year, but the sell-off may be a bit overblown.

2. Target
Big-box retailer Target is another company that's not doing well due to tough economic conditions. Its business relies heavily on discretionary purchases, and that hasn't been a good recipe for success of late. The stock is down 33% this year, and the last time it was at these levels was also back in 2020.

When it last reported earnings in August, its net sales of $25.2 billion were down around 1%, despite the company seeing improvements in sales and traffic trends. The company has a new CEO, Michael Fiddelke, taking over in February. And he's wasting no time in trying to fix things up as he recently sent out a memo announcing 1,800 corporate layoffs in the company's largest restructuring effort in a decade.

Today's Change

(

-0.50

%) $

-0.46

Current Price

$

90.78

Target's stock trades at 10 times earnings so there is a good margin of safety that comes with it. I believe it may be able to rebound within a year or two, especially with its new CEO hitting the ground running and already working on improving profitability.

3. Kimberly-Clark
Normally a safe blue chip stock, shares of Kimberly-Clark have tumbled more than 20% this year. They haven't been priced this low since 2018. The consumer goods company, known for brands such as Huggies and Cottonelle, wasn't doing all that badly until recently, when it announced plans to acquire Kenvue for a whopping $48.7 billion.

Johnson & Johnson spun off Kenvue back in 2023, in an effort to get leaner, focus on growth, and off-load some of the headaches from its consumer business, including some liability relating to talc-based products (Johnson & Johnson would remain on the hook for liabilities related to the U.S. and Canada, but Kenvue would have to take on litigation for other markets). Now, Kimberly-Clark looks like it's willing to take on those challenges, including Tylenol, which Kenvue owns and which has recently come under controversy as President Donald Trump has suggested that there may be a potential link between it and autism.

Today's Change

(

-0.73

%) $

-0.76

Current Price

$

103.09

This acquisition is a perplexing move for Kimberly-Clark, to take on all these challenges for a business such as Kenvue that's struggling to generate any growth of its own. That's why I think Kimberly-Clark may be the worst stock on this list, and it may have the toughest path to turning things around. At 17 times its trailing earnings, it's also the most expensive. Even though the stock's losses are relatively mild compared to the others on this list, they could get a lot worse. I would avoid this stock at all costs.
2025-11-11 03:35 5mo ago
2025-11-10 21:47 5mo ago
China is buying US soybeans again, but uncertainty persists stocknewsapi
SOYB
CNBC's Eunice Yoon speaks with a delegation of American farmers at an import fair in Shanghai, asking whether they're optimistic about selling more soybeans to China as trade tensions ease.
2025-11-11 03:35 5mo ago
2025-11-10 21:51 5mo ago
You Can Still Reap Big Gains Without Buying Tech Stocks stocknewsapi
CTAS WM
If there’s one thing that’s undoubtedly true over the past decade, it’s that technology stocks have been blistering hot.

And it’s been for very understandable reasons – many of these companies’ products have entirely changed the way the world behaves. People stay solely connected through digital channels such as social media, students are now taking their exams online, and consumers are even utilizing digital apps that allow for grocery delivery.

But while all that sounds fun and exciting, many have overlooked simple businesses that aren’t overly flashy. This includes companies that take care of waste management, provide staffing uniforms, and even energy drink providers, to give a few examples.

Many of these companies fall into the Consumer Staples sector, whose businesses face steady demand across many economic conditions. In other words, people will want their trash picked up no matter the state of the economy, and we all obviously enjoy our caffeine buzz.

And perhaps to the surprise of some, these non-technology companies have seen wildly strong performance, with their predictable nature able to provide nice shields against volatility.

Cintas Keeps Gaining

For example, Cintas (CTAS - Free Report) , a provider of uniforms and other workplace supplies to employers, has gained +810% over the last decade, compared with a +325% gain from the S&P 500. 

Cintas’ +24.6% annualized return over the period has undoubtedly excited investors. As shown below, shares have also been considerably less volatile over the last decade, largely weathering 2022 volatility with ease.

Image Source: Zacks Investment Research

Waste Management (WM - Free Report) provides collection, transfer, recycling, resource recovery, and disposal services to residential, commercial, industrial, and municipal customers. Waste Management shares have been steadily strong over the last decade, outpacing the S&P 500’s 325% gain by a decent margin.

And like CTAS, Waste Management shares have largely weathered volatility, particularly so during the 2022 downturn.

Image Source: Zacks Investment Research

Bottom Line

Simply put, you don’t have to buy tech stocks to see great returns. Lesser-discussed companies like Cintas and Waste Management have built consistent, dependable growth by doing the ‘simple’ things exceptionally well. Of course, they’re likely not to impress investors given their less-flashy nature, but sometimes boring is better.  
2025-11-11 03:35 5mo ago
2025-11-10 21:55 5mo ago
Tempus AI: First Positive EBITDA, Huge TAM - Yet The Stock Isn't A Buy stocknewsapi
TEM
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-11-11 03:35 5mo ago
2025-11-10 21:56 5mo ago
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock stocknewsapi
VOR
November 10, 2025 21:56 ET

 | Source:

Vor Biopharma

BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $10.00 per share. The gross proceeds from the offering are expected to be $100 million, before deducting the underwriting discounts and commissions and offering expenses. The offering is expected to close on or about November 12, 2025, subject to customary closing conditions. In addition, Vor Bio has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares are being sold by Vor Bio.

J.P. Morgan, Jefferies, Citigroup and TD Cowen are acting as joint book-running managers for the offering.

The shares of common stock described above are being offered by Vor Bio pursuant to a shelf registration statement filed by Vor Bio with the Securities and Exchange Commission (SEC) that was declared effective by the SEC on March 31, 2025. The offering is being made only by means of a prospectus supplement and an accompanying prospectus that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering were filed with the SEC and are available on the SEC’s website located at http://www.sec.gov. A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus related to this offering, when available, may be obtained from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at [email protected] and [email protected]; Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at (877) 821-7388, or by email at [email protected]; Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or via telephone: (800) 831-9146; or TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, NY 10017, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Vor Bio

Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide.

Forward Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. These statements may be identified by introductory words such as “anticipate,” “believe,” “expects,” “intends,” “may,” “plan,” “should,” “subject to,” “will,” “would” or words of similar meaning, or by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements include statements regarding the timing and completion of the offering, the satisfaction of customary closing conditions related to the offering and the anticipated gross proceeds from the offering. For such statements, Vor Bio claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Vor Bio’s expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering, and those factors disclosed in Vor Bio’s filings with the SEC, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025. These forward-looking statements represent Vor Bio’s judgment as of the time of this release. Vor Bio disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Media & Investor Contacts:
Carl Mauch
[email protected] 

Sarah Spencer
[email protected] 
2025-11-11 03:35 5mo ago
2025-11-10 22:01 5mo ago
FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript stocknewsapi
FGEN
FibroGen, Inc. (FGEN) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST

Company Participants

Thane Wettig - CEO & Director
David DeLucia - Senior VP & CFO

Conference Call Participants

Gaia Vasiliver-Shamis
Andy Hsieh
Matthew Keller - H.C. Wainwright & Co, LLC, Research Division
Chen Lin

Presentation

Operator

Hello, and thank you for standing by. Welcome to FibroGen Third Quarter 2025 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to Gaia Shamis. You may begin.

Gaia Vasiliver-Shamis

Thank you, [ Twanda ]. Good afternoon, everyone, and thank you for joining us today to discuss FibroGen's First Quarter 2025 Financial and Business Results. I'm Gaia Shamis from LifeSci Advisors. Joining me on today's call are Thane Wettig, Chief Executive Officer; and David DeLucia, Chief Financial Officer. Following the prepared remarks, we will open the call to your questions.

I would like to remind you that remarks made on today's call include forward-looking statements about FibroGen. Such statements may include, but are not limited to, collaborations with AstraZeneca and Astellas, financial guidance, the initiation, enrollment, design, conduct and results of clinical trials, regulatory strategies and potential regulatory results, research and development activities, commercial results and results of operations, risks related to our business and certain other business matters.

Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in that statement. A more complete description of these and other material risks can be found in FibroGen's filings with the SEC, including our most recent Form 10-K and Form 10-Q. FibroGen does not undertake any obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. The press release reporting the company's financial results and business update and a webcast of today's conference call

Recommended For You
2025-11-11 03:35 5mo ago
2025-11-10 22:05 5mo ago
CORRECTION FROM SOURCE: Cablevisión Holding Announces its Nine Months and Third Quarter 2025 Results stocknewsapi
CVHSY TEO
Correction: A new webcast link for the conference call BUENOS AIRES, ARGENTINA / ACCESS Newswire / November 10, 2025 / Cablevisión Holding S.A., ("Cablevision Holding", "CVH" or "the Company" - BCBA:CVH)(OTC:CVHSY), controlling shareholder of Telecom Argentina S.A.
2025-11-11 03:35 5mo ago
2025-11-10 22:11 5mo ago
Green Dot Corporation (GDOT) Q3 2025 Earnings Call Transcript stocknewsapi
GDOT
Green Dot Corporation (GDOT) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST

Company Participants

Timothy Willi - Senior Vice President of Finance & Corporate Development
William Jacobs - Interim CEO & Chairman of the Board
Chris Ruppel - Interim President & Chief Revenue Officer
Jess Unruh - Chief Financial Officer

Conference Call Participants

Cristopher Kennedy - William Blair & Company L.L.C., Research Division
George Sutton - Craig-Hallum Capital Group LLC, Research Division

Presentation

Operator

Good day, and welcome to the Green Dot Corporation Third Quarter 2025 Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Timothy Willi of Investor Relations. Please go ahead.

Timothy Willi
Senior Vice President of Finance & Corporate Development

Thank you, and good afternoon, everyone. Today, we are discussing Green Dot's third quarter 2025 financial and operating results. Following our remarks, we'll open the call for your questions. Our most recent earnings release that accompanies this call and webcast can be found at ir.greendot.com.

As a reminder, our comments may include forward-looking statements and expectations regarding future results and performance. Please refer to the cautionary language in the earnings release and in Green Dot's filings with the Securities and Exchange Commission, including our most recent Form 10-K and 10-Q for additional information concerning factors that could cause actual results to differ materially from the forward-looking statements.

During the call, we will refer to our financial measures that do not conform with generally accepted accounting principles. For the sake of clarity, unless otherwise noted, all numbers we talk about today will be on a non-GAAP basis. Information may be calculated differently than similar non-GAAP data presented by other companies. Quantitative reconciliation of our non-GAAP financial information to the directly comparable GAAP financial information appears in today's press release. The content of this

Recommended For You
2025-11-11 03:35 5mo ago
2025-11-10 22:15 5mo ago
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Simulations Plus, Inc. (NASDAQ: SLP) and Encourages Investors with Substantial Losses to Contact the Firm stocknewsapi
SLP
, /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Simulations Plus, Inc. ("Simulations Plus") (NASDAQ: SLP), resulting from allegations of providing potentially misleading business information to the investing public.

If you have information that could assist in the Simulations Plus investigation or if you are a Simulations Plus investor who suffered a loss and would like to learn more, you can provide your information HERE .

You can also contact attorneys Eric Lechtzin or Marc Edelson of Edelson Lechtzin LLP by calling 844-563-5550 ext. 1 or via e-mail at [email protected]  or [email protected] .

THE COMPANY:

Simulations Plus provides software and consulting to support drug discovery and development in the pharmaceutical industry.

THE ALLEGED WRONGDOING:

On April 15, 2025, Simulations Plus hired Grant Thornton as its auditor. After reporting weak preliminary Q3 results in June, citing market uncertainties, its stock dropped more than 24% to close at $20.05 per share. On July 14, 2025, the company posted a $77.2 million charge tied to prior acquisitions and dismissed Grant Thornton, despite the auditor's objections regarding unresolved reporting and internal control issues. Following Grant Thornton's dismissal, the stock fell another 25.76% to close at $12.97 per share.

ABOUT EDELSON LECHTZIN LLP: Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation in cases alleging violations of the federal antitrust laws, breach of fiduciary duties under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.

For more information, please contact:

Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: [email protected]
Email: [email protected]
Web:  www.edelson-law.com 

This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

SOURCE Edelson Lechtzin LLP

Also from this source
2025-11-11 03:35 5mo ago
2025-11-10 22:30 5mo ago
Berkshire Hathaway: Better Than The S&P 500 In Our View stocknewsapi
BRK-A BRK-B IVV SPLG SPXL SPY SSO UPRO VOO
Analyst’s Disclosure:I/we have a beneficial long position in the shares of BRK.B either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-11-11 03:35 5mo ago
2025-11-10 22:31 5mo ago
LevelJump Announces 2025 Third Quarter Results stocknewsapi
JMPHF
November 10, 2025 10:31 PM EST | Source: LevelJump Healthcare Corp.
Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its financial results for the three months and nine months ended September 30, 2025.

Financial and Operational Highlights

Revenues were $4.84 million in the third quarter compared to $4.45 million in the same period the prior year, an increase of 8.7%.

For the nine months ended September 30, 2025, revenues were $14.1 million compared to $12.9 million in the same period in 2024, an increase of 9.1%.

Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA in the third quarter of $836,000.

For the nine months ended September 30, 2025, Canadian Teleradiology Services, Inc. had EBITDA of $3.04 million.

2025 Third Quarter Financial Results

Revenues of $4.85 million in the third quarter of 2025 with a net loss of $(26,378).

EBITDA of $600,677 for the third quarter of 2025.

Revenues of $14.1 million for the nine months ended September 30, 2025, with a net income of $5,754.

EBITDA of $1.90 million for the nine months ended September 30, 2025.

Previously Announced Acquisition

The Company entered into an agreement to acquire two additional diagnostic imaging outpatient clinics located in Calgary, Alberta. The transaction was not approved by one of the vendors landlords and the transaction has been terminated. See the Company's news release dated June 13, 2025.

Management Comments

Mitch Geisler, CEO, commented, "We are very pleased with our Q3 results and year-over-year growth. We continue to focus on increasing clinic revenue with additional patients scans and other organic growth opportunities including our preparations in Alberta to add mammography and increase our fluoroscopy and pain management services."

Non-IFRS Financial Measures

This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity.

For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Consolidated Financial Statements for the three months and nine months ended September 30, 2025, which are available on the Company's website (www.leveljumphealthcare.com) and under the Company's profile on SEDAR (www.sedarplus.ca).

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273960
2025-11-11 03:35 5mo ago
2025-11-10 22:31 5mo ago
Graham Machinery: Not A Bad Time To Cash In After A Sturdy Run (Rating Downgrade) stocknewsapi
GHM
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-11-11 03:35 5mo ago
2025-11-10 22:31 5mo ago
Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call Transcript stocknewsapi
HCAT
Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST

Company Participants

Matt Hopper
Daniel Burton - CEO & Director
Benjamin Albert - President & COO
Jason Alger - Chief Financial Officer

Conference Call Participants

Jared Haase - William Blair & Company L.L.C., Research Division
Jessica Tassan - Piper Sandler & Co., Research Division
Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division
Richard Close - Canaccord Genuity Corp., Research Division
Daniel Grosslight - Citigroup Inc., Research Division
David Larsen - BTIG, LLC, Research Division
Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division
Jeffrey Garro - Stephens Inc., Research Division
Gabrielle Ingoglia - Cantor Fitzgerald & Co., Research Division

Presentation

Operator

Welcome to the Health Catalyst Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Matt Hopper, Senior Vice President of Finance and Head of Investor Relations.

Matt Hopper

Good afternoon, and welcome to Health Catalyst's earnings conference call for the third quarter of 2025, which ended on September 30, 2025. My name is Matt Hopper, Senior Vice President of Finance and Head of Investor Relations. With me today are Dan Burton, our Chief Executive Officer; Ben Albert, our President and Chief Operating Officer; and Jason Alger, our Chief Financial Officer.

A complete disclosure of our results can be found in our press release issued today as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com. As a reminder, today's call is being recorded, and a replay will be available following the conclusion of the call. During today's call, we will make forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding our future growth and our financial outlook for Q4 and fiscal year 2025.

Recommended For You
2025-11-11 02:35 5mo ago
2025-11-10 20:41 5mo ago
Kaltura, Inc. (KLTR) Q3 2025 Earnings Call Transcript stocknewsapi
KLTR
Kaltura, Inc. (KLTR) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST

Company Participants

Ron Yekutiel - Co-Founder, Chairman, President & CEO
John Doherty - Chief Financial Officer

Conference Call Participants

Erica Mannion - Sapphire Investor Relations, LLC
John Jeffrey Hopson - Needham & Company, LLC, Research Division
David Hynes - Canaccord Genuity Corp., Research Division

Presentation

Operator

Good afternoon, everyone, and welcome to the Kaltura Third Quarter 2025 Earnings Call. All material contained in the webcast is the sole property and copyright of Kaltura with all rights reserved. For opening remarks and introductions, I will now turn the call over to Erica Mannion at Sapphire Investor Relations. Please go ahead, Erica.

Erica Mannion
Sapphire Investor Relations, LLC

Thank you, operator. I'm joined by Ron Yekutiel, Kaltura's Co-Founder, Chairman, President and Chief Executive Officer; and John Doherty, Chief Financial Officer. Ron will begin with a summary of the results for the third quarter ended September 30, 2025, and provide a business update. John will review the financial results for the third quarter of 2025 in greater detail, followed by the company's outlook for the fourth quarter and full year of 2025. We will then open the call for questions.

Please note that this call will include forward-looking statements within the meaning of the federal securities laws, but not limited to, statements regarding Kaltura's expected future financial results and management's expectations and plans for the business, including our planned acquisition announced earlier today. These statements are neither promises nor guarantees and involve risks and uncertainties that may cause actual results to differ materially from those discussed here.

Important factors that could cause actual results to differ from forward-looking statements can be found in the Risk Factors section of Kaltura's annual report on Form 10-K for the fiscal year ended December 31, 2024, and

Recommended For You
2025-11-11 02:35 5mo ago
2025-11-10 20:42 5mo ago
Tesla investor support for Elon Musk's massive pay plan was lower in 2025 than in 2018 stocknewsapi
TSLA
Tesla shareholders voted last week to give CEO Elon Musk a record pay package, one that could net him about $1 trillion in company stock over the next decade. But Musk received less support than he did for an earlier pay plan in 2018.

Setting aside holdings owned by board members and executives, about 66% of shares tabulated in the vote were in favor of the package, according to a filing on Friday. When shareholders voted on the 2018 plan, that number was 73%, according to an analysis by Andrew Droste, head of corporate governance at investment firm Columbia Threadneedle.

In announcing the preliminary results on Thursday at the company's annual shareholders meeting, Tesla said the plan received 75% support among voting shares. The company count included insiders like Musk, who held around a 15% stake in Tesla going into the proxy and was allowed to vote his shares.

The decline from the prior vote follows a tumultuous stretch for Musk and Tesla. Sales slumped in the first half of the year, in part because of Musk's inflammatory political rhetoric and his work for the Trump administration, slashing the size of the federal government. Tesla's brand value has also deteriorated.

Still, Droste said in an email that even at a 66% level, the vote represents "broad support for Elon among Tesla's shareholder base." Most investors recognize that Tesla and Elon Musk are "inextricably linked," he wrote, and were "unwilling to risk his potential departure by allowing this vote to fail."

Board members recommended shareholders approve the pay plan, which they introduced in September. Top proxy advisors Glass Lewis and ISS had recommended that investors vote against it.

The pay package for Musk, already the world's richest person, consists of 12 tranches of shares to be granted if Tesla hits certain milestones over the next decade. The first tranche of stock gets paid out if Tesla hits a market capitalization of $2 trillion, about $500 billion more than the current valuation. Awards tied to market cap gains are paired with operational achievements.

Musk could still collect more than $50 billion by hitting a handful of the more attainable goals laid out for him by the board in the new pay plan. There are also a list of "covered events" in the award terms that would allow him to earn his shares without meeting required operational milestones.

Tesla didn't immediately respond to a request for comment.

watch now
2025-11-11 02:35 5mo ago
2025-11-10 20:45 5mo ago
JSPR DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action - JSPR stocknewsapi
JSPR
November 10, 2025 8:45 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Jasper Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Jasper Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=45109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (2) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of Jasper's products, including briquilimab; (3) the foregoing increased the likelihood of disruptive cost-reduction measures; (4) accordingly, Jasper's business and/or financial prospects, as well as briquilimab's clinical and/or commercial prospects, were overstated; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Jasper Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=45109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273943
2025-11-11 02:35 5mo ago
2025-11-10 20:45 5mo ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX stocknewsapi
TLX
NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 9, 2026 in the securities class action first filed by the Firm.

SO WHAT: If you purchased Telix securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Telix class action, go to https://rosenlegal.com/submit-form/?case_id=43778 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 9, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) Defendants materially overstated the quality of Telix’s supply chain and partners; and (3) as a result, defendants’ statements about Telix’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Telix class action, go to https://rosenlegal.com/submit-form/?case_id=43778   or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
2025-11-11 02:35 5mo ago
2025-11-10 20:47 5mo ago
Tuktu Resources Ltd. Schedules Requisitioned Special Meeting stocknewsapi
JAMGF
November 10, 2025 8:47 PM EST | Source: Tuktu Resources Ltd.
Calgary, Alberta--(Newsfile Corp. - November 10, 2025) - Tuktu Resources Ltd. (TSXV: TUK) ("Tuktu" or the "Company"), a junior oil and gas producer based in Calgary, Alberta, announces that it has scheduled a special meeting (the "Meeting") of the Company's shareholders in response to a requisition from certain shareholders who purport to hold approximately 31% of the Company's outstanding Common Shares, as noted in Tuktu's press release dated October 23, 2025. The Company's Board of Directors (the "Board") has convened the Meeting in keeping with its commitment to good governance.

The Board does not support the proposed actions by the requisitioning shareholders.

The Board appreciates the continued engagement of Tuktu shareholders and expresses confidence in the Company's strategic direction under the oversight of the current Board and the leadership of its recently appointed Chief Executive Officer, Mr. Jeremy Hodder. Mr. Hodder is conducting a comprehensive strategic review of Tuktu's oil and gas assets and operations. He, together with Tuktu's newly constituted technical team under his leadership, are focused on enhancing Tuktu's underperforming assets and significantly improving the operational excellence and the direction thereof. The Board expresses confidence in the Company's new strategic direction and looks forward to constructive dialogue with all shareholders as it advances its plans to create long-term value.

The Meeting is scheduled to take place on Thursday, January 15, 2026, at a time and location to be determined. The record date for determining shareholders entitled to notice of the Meeting and to vote at the Meeting is set as December 1, 2025.

Tuktu will provide further details in a management information circular and related meeting materials, which will be mailed to shareholders and posted on the Company's website and its SEDAR+ profile (www.sedarplus.ca), as required by applicable law.

This news release is not intended to, and does not, constitute a solicitation of proxies in relation to the Meeting. Any solicitation of proxies, by or on behalf of management of Tuktu in relation to the Meeting will take place upon and following the dissemination of the management information circular and other meeting materials in accordance with applicable law.

Tuktu Resources Ltd.
1750, 444 - 5th Avenue S.W.
Calgary, Alberta T2P 2T8

Forward-Looking Statements

This news release contains "forward-looking statements" and "forward-looking information" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by words such as "intend", "believe", "estimate", "expect", "may", "will", and similar expressions (including negative and grammatical variations). Forward-looking statements in this news release include statements regarding, among other things: Tuktu's business, strategy, goals, objectives, operations and plans; the Company's strategic vision; expectations in respect of the Company's strategic review of Tuktu's oil and gas assets and operations; the ability of Mr. Hodder and the Company's newly constituted technical team to significantly improve the operational excellence and direction of the Company's assets; the new strategic direction of the Company; the Company's approach to shareholder value creation; statements regarding the Meeting, including timing and format thereof; and the dissemination of a management information circular in respect of the Meeting, including timing thereof. Although Tuktu believes the expectations reflected in such forward-looking statements are reasonable based on information currently available and the experience of its officers and directors, undue reliance should not be placed on them because Tuktu can give no assurance they will prove to be correct. Forward-looking statements reflect the Company's current views and are subject to risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied, including, without limitation: potential delays or changes in scheduling, fixing the record date for, or holding the Meeting; changes to the Meeting's date, time, location or format; challenges to, or changes in, the validity of the requisition or record date; court, regulatory or stock exchange requirements; printing, mailing or delivery delays; the actions of the requisitioning shareholders or other stakeholders; potential litigation; competitive factors; supply and demand dynamics in the oil and gas industry; stock market and financial system volatility; fluctuations in currency and interest rates; inflation; risks of war, hostilities, civil unrest, pandemics, and political or economic instability and their effects on commodity prices and the energy industry; determinations by the Organization of Petroleum Exporting Countries and other countries regarding production levels and the risk of an extended period of low oil and natural gas prices; the imposition or expansion of tariffs or other restrictive trade measures and any retaliatory countermeasures; changes in laws and regulations (including environmental, regulatory and taxation) and how such changes may be interpreted and applied to the Company; availability and adequacy of insurance; difficulties in obtaining or maintaining necessary regulatory approvals; and general economic, business, operational and logistical conditions. Tuktu has made assumptions in preparing these forward-looking statements, including, among others: the timely preparation, approval, printing, mailing and posting of Meeting materials; the accuracy of shareholder records; the applicability and interpretation of securities laws and stock exchange policies; availability of required third-party services; and the Company's ability to execute its operational plans within expected timelines and budgets. The impact of any one assumption, risk, uncertainty or other factor on forward-looking statements cannot be determined with certainty, as these are interdependent and Tuktu's future course of action depends on assessing all information available at the relevant time. For additional risk factors relating to Tuktu, please refer to the Company's annual information form for the year ended December 31, 2024, and its most recent management's discussion and analysis, each available under the Company's profile on SEDAR+ at www.sedarplus.ca. Forward-looking statements in this news release are made as of the date hereof, and the Company does not undertake any obligation to update or revise them to reflect new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273953
2025-11-11 02:35 5mo ago
2025-11-10 20:47 5mo ago
Is Lemonade Stock a Buy After Investment Firm X-Square Capital Doubled Its Stake? stocknewsapi
LMND
What happenedAccording to a Securities and Exchange Commission (SEC) filing dated November 10, 2025, investment advisor X-Square Capital, LLC purchased 142,628 additional shares of Lemonade (LMND +5.13%) during the third quarter.

The firm’s stake increased to 213,199 shares, worth $11.41 million as of September 30, 2025. The position now accounts for 3.56% of X-Square’s $320.15 million in reportable U.S. equity assets.

What else to knowX-Square Capital added to its Lemonade position, which now makes up 3.56% of its 13F assets.

Top holdings after the filing: 

HIMS: $24.25 million (7.6% of AUM)LMND: $11.41 million (3.6% of AUM)ASTS: $11.20 million (3.5% of AUM)SPY: $11.14 million (3.5% of AUM)AMD: $10.07 million (3.1% of AUM)As of November 7, 2025, shares were priced at $75.02, up 130.34% over the past year, outperforming the S&P 500 by 152 percentage points.

Company OverviewMetricValueRevenue (TTM)$600.70 millionNet Income (TTM)($204.00 million)Price (as of market close 11/07/25)$75.02One-Year Price Change130.34%Company SnapshotLemonade, Inc. offers renters, homeowners, pet, car, life, and landlord insurance products, generating revenue primarily from insurance premiums and related services.The company operates a digital-first, direct-to-consumer business model leveraging artificial intelligence to underwrite, price, and service policies efficiently.Lemonade targets individuals and households in the United States and Europe seeking streamlined, technology-driven insurance solutions.Lemonade, Inc. is a technology-driven insurance provider focused on property, casualty, and specialty lines across the U.S. and Europe. The company differentiates itself through a fully digital platform and AI-powered underwriting, enabling rapid customer onboarding and claims processing.

Lemonade's strategy emphasizes customer-centric design and operational efficiency to compete in the evolving insurance landscape.

Foolish takeX-Square Capital increasing its stake in Lemonade is noteworthy because the fund more than doubled its previous holding of 70,571 shares at the end of the second quarter. The buy rocketed Lemonade to the number two stock out of more than 160 holdings, suggesting X-Square Capital holds a bullish outlook towards the company.

The fund's big buy makes sense given Lemonade's third quarter performance. The insurance provider's customer count rose a strong 24% year over year. This resulted in outstanding Q3 revenue growth of 42% year over year to $194.5 million.

Consequently, Lemonade raised its 2025 full-year sales guidance. It now expects revenue to come in between $727 million to $732 million, which would be strong growth over 2024's $526.5 million.

However, the company is not profitable. It exited Q3 with a net loss of $37.5 million. Still, that's an improvement over the prior year's net loss of $67.7 million.

Lemonade looks like a promising investment, given its customer and revenue growth as well as its shrinking net loss. Shares are hovering near the 52-week high of $81.90 reached on Nov. 6, so the prudent approach is to wait for the stock to drop before deciding to buy.

GlossaryAssets Under Management (AUM): The total market value of investments managed on behalf of clients by a fund or firm.
Reportable Assets: Investments that a fund is required to disclose in regulatory filings, such as those reported on SEC Form 13F.
Net Position Change: The difference in the value of a fund's holding in a security after buying or selling shares.
13F Assets: U.S. equity securities that institutional investment managers must report quarterly to the SEC on Form 13F.
Direct-to-Consumer: A business model where products or services are sold directly to end customers, bypassing intermediaries.
Underwrite: The process of evaluating and assuming risk in exchange for a premium, commonly used in insurance and securities issuance.
Quarter: A three-month period used by companies for financial reporting and performance measurement.
TTM: The 12-month period ending with the most recent quarterly report.
Outperforming: Achieving a better return or performance compared to a benchmark or index.
Stake: The amount of ownership or shares held in a company by an investor or institution.
Filing: An official document submitted to a regulatory authority, such as the SEC, often disclosing financial or ownership information.
AI-powered Underwriting: Using artificial intelligence to assess risk and determine insurance policy terms and pricing.

Robert Izquierdo has positions in Advanced Micro Devices. The Motley Fool has positions in and recommends Advanced Micro Devices, Hims & Hers Health, and Lemonade. The Motley Fool has a disclosure policy.
2025-11-11 02:35 5mo ago
2025-11-10 20:51 5mo ago
Cannae Holdings, Inc. (CNNE) Q3 2025 Earnings Call Transcript stocknewsapi
CNNE
Cannae Holdings, Inc. (CNNE) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST

Company Participants

Ryan Caswell - Chief Executive Officer
Bryan Coy - Executive VP & CFO

Conference Call Participants

Jamie Lillis - SOLEBURY TROUT LLC
Kenneth Lee - RBC Capital Markets, Research Division
Isaac Sellhausen - Oppenheimer & Co. Inc., Research Division

Presentation

Operator

Good afternoon, ladies and gentlemen, and welcome to the Cannae Holdings, Inc. Third Quarter 2025 Financial Results Conference Call. [Operator Instructions]. As a reminder, this conference call is being recorded, and a replay is available through 11:59 p.m. Eastern Time on November 24, 2025. With that, I would like to turn the call over to Jamie Lillis of Solebury Strategic Communications. Please go ahead.

Jamie Lillis
SOLEBURY TROUT LLC

Thank you, operator, and all of you for joining us. On the call today, we have Cannae's CEO, Ryan Caswell; and Bryan Coy, our Chief Financial Officer. But before we begin, I would like to remind listeners that this conference call and the Q&A following our remarks may contain forward-looking statements that involve a number of risks and uncertainties. Statements that are not historical facts, including statements about Cannae's expectations, hopes, intentions or strategies regarding the future are forward-looking statements. Forward-looking statements are based on management's beliefs as well as assumptions made by and information currently available to management.

Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected. The company undertakes no obligation to update any forward-looking statements, whether as a result of new information, further future events or otherwise.

The risks and uncertainties, which forward-looking statements are subject to include, but are not limited to, the risks and other factors detailed in our quarterly shareholder letter, which was released

Recommended For You
2025-11-11 02:35 5mo ago
2025-11-10 20:51 5mo ago
DocGo Inc. (DCGO) Q3 2025 Earnings Call Transcript stocknewsapi
DCGO
DocGo Inc. (DCGO) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST

Company Participants

Mike Cole - Vice President of Investor Relations
Lee Bienstock - CEO & Director
Norman Rosenberg - Treasurer & CFO

Conference Call Participants

Philip Chickering
Sarah James - Cantor Fitzgerald & Co., Research Division
Ryan MacDonald - Needham & Company, LLC, Research Division
Jenny Shen - BTIG, LLC, Research Division
Aditya Dagaonkar

Presentation

Operator

Good afternoon, ladies and gentlemen, and welcome to the DocGo Third Quarter Earnings Conference Call. [Operator Instructions] This call is being recorded on Monday, November 10, 2025. I would now like to turn the conference call over to Mr. Mike Cole, Vice President, Investor Relations. Please go ahead.

Mike Cole
Vice President of Investor Relations

Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements. All statements made in this conference call other than statements of historical fact are forward-looking statements. The words may, will, plan, potential, could, goal, outlook, design, anticipate, aim, believe, estimate, expect, intend, guidance, confidence, target, project and other similar expressions may be used to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance, and we cannot assure you that we will achieve or realize our plans, intentions, outcomes, results or expectations.

Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond our control and which may cause our actual results or outcomes or the timing of results or outcomes to differ materially from those contained in our forward-looking statements. These risks, uncertainties and assumptions include, but are not limited to, those discussed in risk factors and elsewhere in DocGo's annual report on Form 10-K, quarterly reports on Form 10-Q, our earnings release for this quarter and other reports and statements filed by DocGo with the SEC to

Recommended For You
2025-11-11 02:35 5mo ago
2025-11-10 21:00 5mo ago
Where Will Nvidia Stock Be in 5 Years? stocknewsapi
NVDA
The iconic chipmaker continues to soar to incredible highs.

It's been three years since OpenAI's ChatGPT introduced the world to generative artificial intelligence (AI), and the booming industry shows no signs of slowing down as technology giants continue to pour billions into AI chips and other forms of infrastructure. With shares up by an eyewatering 1,300% over the last half-decade, Nvidia (NVDA +5.82%) is one of the most obvious beneficiaries of this megatrend.

That said, the iconic chipmaker now boasts a market cap of $4.83 trillion, which makes it comfortably the largest company on earth. For comparison, the entire nation of Germany had a gross domestic product (GDP) of just $4.66 trillion in 2024. And while that's not an apples-to-apples comparison, it does show the level of value we are dealing with. Nvidia's massive size is sure to leave investors wondering if further growth is even possible. Let's explore the pros and cons of the stock to decide what the next five years might have in store.

Today's Change

(

5.82

%) $

10.94

Current Price

$

199.09

Business continues to boom
Perhaps the most surprising thing about Nvidia's $4.66 trillion price tag is that it isn't as expensive as it looks when you consider key factors like growth and profitability. Fiscal second-quarter earnings make the company look more like a fast-growing start-up than an established behemoth.

Revenue soared 56% year over year to $46.7 billion, driven by continued strength in the data center segment, where Nvidia sells its most advanced enterprise AI chips like Blackwell. With a gross margin of 72% the company manages to sell its cutting-edge hardware at a tremendous markup. For context, software specialist Microsoft only boasts a gross margin of 69%, despite typically not even selling physical products.

Nvidia maintains its incredible pricing power because of a strong economic moat built around its CUDA ecosystem of software and tools designed to work best with Nvidia hardware. This advantage makes it hard for clients to switch to competitors (like Advanced Micro Devices' MI350x Instinct series), even if they offer similar raw capabilities. Unsurprisingly, the company's bottom line continues to surge, with second-quarter net income jumping 59% year over year to $26.4 billion.

What are the challenges?
With a forward price-to-earnings (P/E) multiple of just 30, Nvidia stock is downright cheap when you look at its current fundamentals. For context, the Nasdaq-100 has an average forward P/E of 28, and few companies on the index can compare to Nvidia's explosive growth and strong moat. That being said, sometimes investors need to look past the numbers.

Even though Nvidia's valuation makes perfect sense compared to its profitability and growth, the company still feels too big for comfort. And there are some compelling reasons why. For starters, there are questions about the sustainability of the chip purchases fueling its growth.

Image source: Getty Images.

According to The Wall Street Journal, tech giants including Alphabet, Meta Platforms, Microsoft, and Amazon spent a whopping $360 billion in capital expenditures over the last 12 months, with much of that going to Nvidia hardware to build out data centers. And while this might not be a traditional bubble, there is a real possibility that this level of spending could slow dramatically if generative AI doesn't turn out to be as profitable as expected. There are some early warning signs.

An August MIT study found that 95% of generative AI pilots fail to create meaningful value for companies. And the industry's frontrunner, OpenAI (a major customer for Nvidia), may have lost a whopping $11.5 billion in the most recent quarter because of the high costs of running its large language models (LLMs). With such dizzying losses, it may be a matter of time before shareholders revolt and companies start reevaluating the amount they are spending on AI hardware. If this happens, Nvidia's growth and margins could quickly come under pressure.

Where will Nvidia stock be in five years?
While Nvidia looks fairly valued compared to its explosive growth and profits, the company is overexposed to the generative AI industry, and that makes the stock riskier than its raw fundamentals might suggest. Potential investors may want to sit on the sidelines for now.

Will Ebiefung has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Meta Platforms, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
2025-11-11 02:35 5mo ago
2025-11-10 21:01 5mo ago
Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 Earnings Call Transcript stocknewsapi
ARCT
Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST

Company Participants

Neda Safarzadeh - Vice President and Head of IR/PR & Marketing
Joseph Payne - Founder, President, CEO & Director
Andrew Sassine - CFO & Director

Conference Call Participants

Yasmeen Rahimi - Piper Sandler & Co., Research Division
Jake Batchelder - William Blair & Company L.L.C., Research Division
Boran Wang - Guggenheim Securities, LLC, Research Division
Angela Qian - Canaccord Genuity Corp., Research Division
Kuan-Hung Lin - Wells Fargo Securities, LLC, Research Division
Joohwan Kim
Thomas Shrader - BTIG, LLC, Research Division
Yale Jen - Laidlaw & Company (UK) Ltd., Research Division
Lili Nsongo - Leerink Partners LLC, Research Division

Presentation

Operator

Good afternoon, everyone. Welcome to the Arcturus Therapeutics Third Quarter 2025 Earnings Call. [Operator Instructions] Also, today's call is being recorded. [Operator Instructions] Now at this time, I'd like to turn things over to Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing. Please go ahead, ma'am.

Neda Safarzadeh
Vice President and Head of IR/PR & Marketing

Thank you, operator. Good afternoon, and welcome to Arcturus Therapeutics Quarterly Financial Update and Pipeline Progress Call. Today's call will be led by Joe Payne, our President and CEO; and Andy Sassine, our CFO. Dr. Pad Chivukula, our CSO and COO, will join them for the Q&A session. Before we begin, I would like to remind everyone that the statements made during this call regarding matters that are not historical facts are forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, performance and achievements to differ materially from those expressed or implied by the statement. Please see the forward-looking statement disclaimer on the company's press release

Recommended For You
2025-11-11 02:35 5mo ago
2025-11-10 21:02 5mo ago
5 Warren Buffett Stocks to Hold Forever stocknewsapi
AAPL AMZN AXP CVX KR
Buffett's investing legacy will continue even after he steps away from Berkshire Hathaway.

It's hard to believe that this is the last quarter that the legendary Warren Buffett will be leading Berkshire Hathaway -- the former textile company that he turned into a massive conglomerate with its fingers in real estate, insurance, railroads, and energy.

Over Buffett's 60-year career, he's also assembled a mighty investment portfolio for Berkshire Hathaway, comprising dozens of companies and valued at more than $300 billion. Buffett's buy-and-hold investment style led Berkshire Hathaway to massive gains, compounding 19.9% annually versus the S&P 500's compounded annual gain of 10.4%.

Buffett, now 95, is retiring at the end of the year, but the lessons he's taught us all will persevere -- find companies with strong management, leading positions in their industries, reliable revenues, and strong histories of earnings.

As you consider your investing portfolio in a post-Buffett world, here are five stocks that provide an outstanding starting point for any portfolio.

Image source: The Motley Fool.

1. American Express
Berkshire Hathaway owns a massive 22% stake in credit card giant American Express (AXP 0.18%) -- notable because its stake in competitors Visa and Mastercard are only 0.4% each. So why does Buffett like American Express so much?

Today's Change

(

-0.18

%) $

-0.66

Current Price

$

367.88

First, the company has a unique position, in that it caters to a more affluent clientele through its business credit accounts and Gold and Platinum individual credit accounts. Its rewards and benefits, including travel and entertainment experiences, are unmatched. That's why American Express can afford to upcharge its Platinum card annual fee to a whopping $895 -- and why customers are willing to pay it.

Secondly, American Express also makes personal loans, which is a service that Mastercard and Visa don't offer. American Express earned $5.97 billion in the third quarter on interest from loans, providing a meaningful extra revenue stream.

2. Amazon
Buffett famously was late to invest in Amazon (AMZN +1.63%), but he's surely been happy with the investment. Buffett likes companies that have leading roles in their industries, and Amazon fits the bill two ways -- its huge e-commerce division and its industry-leading cloud computing division.

Today's Change

(

1.63

%) $

3.99

Current Price

$

248.40

Amazon.com generated $147.16 billion in revenue from its international and North American sales, but it only has a small 4% profit margin there. Amazon Web Services (AWS) brings in less revenue at $33 billion in the third quarter, but with a profit margin of 34.6%, it's become a moneymaker that is getting stronger every quarter.

Barclays analyst Ross Sandler wrote glowingly about the potential of AWS in a recent research note. "Despite playing a bit of catch-up, AWS has secured significant AI capacity over the next several years," he wrote. "We expect growth to accelerate from here."

3. Apple
Apple (AAPL +0.43%) has long been Berkshire Hathaway's biggest holding. And even though Buffett's team reduced its shares this year, Apple stock still makes up 24.1% of Berkshire Hathaway's overall portfolio, with 280 million shares valued at $75.5 billion.

Today's Change

(

0.43

%) $

1.15

Current Price

$

269.36

Apple's biggest product is still the iPhone, which provided $49 billion of Apple's $102.4 billion in sales for the fiscal fourth quarter of 2025. But the area that I think people underappreciate is the lucrative Services division, which includes the App Store, Apple Pay, Apple Music, and Apple TV. Services brought in $28.7 billion in the fourth quarter, up 15.1% from a year ago.

Apple's revenues have been flat for a couple of years, but it showed improvement in the second half to push annual revenue above $400 billion for the first time.

4. Kroger
Kroger (KR 0.71%) isn't as flashy as others on this list, but I don't think anyone could ever accuse Buffett of being flashy, either. Instead, it's a classic defensive play. Even when inflation is up or the economy is on shaky ground, people are going to need groceries. That's why Berkshire Hathaway's portfolio includes 50 million shares of Kroger stock.

Kroger has more than 2,700 stores and operates brands that include Kroger, Fred Meyer, Ralph's, and Harris Teeter. It also maintains more than 40 food production and manufacturing facilities for making private-label, low-cost products. Kroger has been emphasizing these brands as of late as they are cheaper than name-brand items and give Kroger a bigger profit margin.

These store brands are usually much cheaper than name-brand items and provide Kroger with greater profit margins -- particularly when customers are looking to stretch their grocery dollars.

5. Chevron
Buffett believes in energy stocks, and with Chevron (CVX +0.41%), Berkshire Hathaway has one of the biggest. Its 122 million shares mean Berkshire has a 6% stake in the multinational energy company.

And Chevron is rebounding nicely this year after hitting a low in April. Currently the stock price is up 7% in 2025, despite lower oil prices and global tensions.

Chevron set records in the third quarter for production, with U.S. production up 27% and global production increasing 21% from a year ago. But because prices are lower, Chevron's revenue was down from last year -- it reported $3.53 billion in the third quarter, versus $4.48 billion a year ago. Earnings per share of $1.82 were down from $2.48 in the third quarter of 2024.

While this hasn't been the best year for Chevron stock, it's a solid long-term play. And its dividend yield of 4.5% is a welcome addition to any portfolio.
2025-11-11 02:35 5mo ago
2025-11-10 21:05 5mo ago
ROSEN, A LONGSTANDING FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK stocknewsapi
CYTK
November 10, 2025 9:05 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Cytokinetics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Cytokinetics class action, go to https://rosenlegal.com/submit-form/?case_id=45298 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 17, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements regarding the timeline for the New Drug Application ("NDA") submission and approval process for aficamten. Specifically, defendants represented that Cytokinetics expected approval from the U.S. Food and Drug Administration ("FDA") for its NDA for aficamten in the second half of 2025, based on a September 26, 2025 Prescription Drug User Fee Act ("PDUFA") date, and failed to disclose material risks related to Cytokinetics' failure to submit a Risk Evaluation and Mitigation Strategy ("REMS") that could delay the regulatory process. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Cytokinetics class action, go to https://rosenlegal.com/submit-form/?case_id=45298 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273944
2025-11-11 02:35 5mo ago
2025-11-10 21:06 5mo ago
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM stocknewsapi
DXCM
NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”) of the important December 29, 2025 lead plaintiff deadline.

SO WHAT: If you purchased DexCom securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the DexCom class action, go to https://rosenlegal.com/submit-form/?case_id=28133 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 29, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) DexCom had made material design changes to the G6 and G7 continuous glucose monitoring (“CGM”) systems that were unauthorized by the U.S. Food and Drug Administration (the “FDA”); (2) the foregoing design changes rendered the G6 and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (3) accordingly, defendants’ purported enhancements to the G7, as well as the device’s reliability, accuracy, and functionality, were overstated; (4) Defendants downplayed the true scope and severity of the issues and health risks posed by adulterated G7 devices; (5) all the foregoing subjected DexCom to an increased risk of heightened regulatory scrutiny and enforcement action, as well as significant legal, reputational, and financial harm; and (6) as a result, defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the DexCom class action, go to https://rosenlegal.com/submit-form/?case_id=28133 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
2025-11-11 02:35 5mo ago
2025-11-10 21:07 5mo ago
FLR DEADLINE NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important November 14 Deadline in Securities Class Action - FLR stocknewsapi
FLR
November 10, 2025 9:07 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fluor Corporation (NYSE: FLR) between February 18, 2025 and July 31, 2025, both dates inclusive (the "Class Period"), of the important November 14, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Fluor securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Fluor class action, go to https://rosenlegal.com/submit-form/?case_id=44868 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 14, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and misleading statements and/or failed to disclose that: (1) costs associated with the Gordie Howe International Bridge ("Gordie Howe"), the Interstate 365 Lyndon B. Johnson ("I-635/LBJ") and Interstate 35E ("I-35") highways in Texas projects were growing because of, inter alia, subcontractor design errors, price increases, and scheduling delays; (2) the foregoing, as well as customer reduction in capital spending and client hesitation around economic uncertainty, was having, or was likely to have, a significant negative impact on Fluor's business and financial results; (3) accordingly, Fluor's financial guidance for the full year 2025 was unreliable and/or unrealistic, the effectiveness of Fluor's risk mitigation strategy was overstated, and the impact of economic uncertainty on Fluor's business and financial results was understated; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Fluor class action, go to https://rosenlegal.com/submit-form/?case_id=44868 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273942
2025-11-11 02:35 5mo ago
2025-11-10 21:08 5mo ago
Ecopetrol Group Releases Its First Financial Sustainability Report, Incorporating Reference Elements from the International Sustainability Standards Board (ISSB) Framework stocknewsapi
EC
, /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) announces that it has published its first 2024 Financial Sustainability Report, in line with its commitment to transparency, sustainable value creation, and a fair and equitable energy transition for the country.

This document marks a milestone in the evolution of sustainability disclosure practices by consolidating the content previously presented separately under the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD) and the metrics of the Sustainability Accounting Standards Board (SASB) into a single report, incorporating reference elements from the International Sustainability Standards Board ("ISSB") framework.

This unified report has been implemented in response to the need to simplify, standardize, and enhance the value of sustainability information disclosed to the market. It is structured around the Ecopetrol's pillars of governance, strategy, risk and opportunity management, metrics, and targets.

The full report is available at the following link:

https://www.ecopetrol.com.co/wps/portal/Home/sostecnibilidad/reportes-estandares/Informesgestionsostenibilidad 

Ecopetrol is the largest company in Colombia and one of the main integrated energy companies in the American continent, with more than 19,000 employees. In Colombia, it is responsible for more than 60% of the hydrocarbon production of most transportation, logistics, and hydrocarbon refining systems, and it holds leading positions in the petrochemicals and gas distribution segments. With the acquisition of 51.4% of ISA's shares, the company participates in energy transmission, the management of real-time systems (XM), and the Barranquilla - Cartagena coastal highway concession. At the international level, Ecopetrol has a stake in strategic basins in the American continent, with Drilling and Exploration operations in the United States (Permian basin and the Gulf of Mexico), Brazil, and, through ISA and its subsidiaries, Ecopetrol holds leading positions in the power transmission business in Brazil, Chile, Peru, and Bolivia, road concessions in Chile, and the telecommunications sector.

For more information, please contact:

Head of Capital Markets
Carolina Tovar Aragón
Email: [email protected]

Head of Corporate Communications
Marcela Ulloa
Email: [email protected]

SOURCE Ecopetrol S.A.
2025-11-11 02:35 5mo ago
2025-11-10 21:11 5mo ago
MOH DEADLINE ALERT: ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOH stocknewsapi
MOH
November 10, 2025 9:11 PM EST | Source: The Rosen Law Firm PA
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), of the important December 2, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Molina securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Molina class action, go to https://rosenlegal.com/submit-form/?case_id=45913 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 2, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose to investors: (1) material, adverse facts concerning Molina's "medical cost trend assumptions;" (2) that Molina was experiencing a "dislocation between premium rates and medical cost trend;" (3) that Molina's near term growth was dependent on a lack of "utilization of behavioral health, pharmacy, and inpatient and outpatient services;" (4) as a result of the foregoing, Molina's financial guidance for fiscal year 2025 was substantially likely to be cut; and (5) as a result of the foregoing, defendants' positive statements about Molina's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Molina class action, go to https://rosenlegal.com/submit-form/?case_id=45913 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273865
2025-11-11 02:35 5mo ago
2025-11-10 21:11 5mo ago
Sangoma Technologies Corporation (STC:CA) Q1 2026 Earnings Call Transcript stocknewsapi
SANG STC
Sangoma Technologies Corporation (STC:CA) Q1 2026 Earnings Call November 10, 2025 5:30 PM EST

Company Participants

Samantha Reburn - Chief Legal & Administrative Officer and Corporate Secretary
Charles Salameh - CEO & Director
Jeremy Wubs - Chief Operating Officer
Lawrence Stock - Chief Financial Officer

Conference Call Participants

Gavin Fairweather - Cormark Securities Inc., Research Division
Suthan Sukumar - Stifel Nicolaus Canada Inc., Research Division
David Kwan - TD Cowen, Research Division
Mike Latimore - Northland Capital Markets, Research Division
Robert Young - Canaccord Genuity Corp., Research Division

Presentation

Operator

Thank you for standing by. This is the conference operator. Welcome to the Sangoma Investor Conference Call. [Operator Instructions]. The conference is being recorded.

I would now like to turn the conference over to Samantha Reburn, Chief Legal Officer. Please go ahead, Ms. Reburn.

Samantha Reburn
Chief Legal & Administrative Officer and Corporate Secretary

Thank you, operator. Hello, everyone, and welcome to Sangoma's First Quarter of Fiscal Year 2026 Investor Call. We are recording the call and we will make it available on our website for anyone who is unable to join us live.

I'm here today with Charles Salameh, Sangoma's Chief Executive Officer; Jeremy Wubs, Chief Operating and Marketing Officer; and Larry Stock, Chief Financial Officer. Charles will provide a high-level overview of the quarter. Jeremy and Larry will take you through the operating results for the first quarter of fiscal year 2026, which ended on September 30, 2025.

Following their presentation, we will open the floor for Q&A with analysts. We will discuss the press release that was distributed earlier today, together with the company's financial statements and MD&A, which are available on SEDAR+, EDGAR and our website. As a reminder, Sangoma reports under International Financial Reporting Standards, IFRS. And during the call, we may refer to terms such as adjusted EBITDA and free cash flow, which are non-IFRS measures, but defined in our MD&A.

Recommended For You
2025-11-11 02:35 5mo ago
2025-11-10 21:12 5mo ago
Oil and Natural Gas Technical Analysis: Crude Faces Resistance While Gas Extends Rally stocknewsapi
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP
Quick Links:

By

:

Published: Nov 11, 2025, 02:12 GMT+00:00

Oil remains in a tight range as supply risks offset concerns about a surplus, natural gas exhibits bullish momentum despite overbought signals, and the U.S. dollar index nears resistance with a potential pullback.

Oil prices held in a tight range as markets reacted to fresh supply threats. U.S. sanctions and drone attacks on Russian refineries raised concerns about refined fuel availability. These disruptions, along with U.S. refinery outages, lifted gasoline and diesel futures. Despite the rebound, gains in crude prices remained limited due to ongoing fears of a global supply surplus.

Moreover, Russian oil operations are under growing pressure. Ukrainian drone attacks halted production at Lukoil’s Volgograd refinery. On the other hand, the company also declared force majeure in Iraq, adding to market concerns. The approaching U.S. business cutoff deadline and the collapse of Lukoil’s asset sale to Gunvor further add to market risks. These developments threaten short-term refined product supply but have not yet significantly affected crude exports. Despite supply risks, oil remains vulnerable to downside pressure.

WTI Crude Oil (CL) Technical Analysis
WTI Oil Daily Chart – Consolidation
The daily chart for WTI crude oil shows that the price is consolidating below the $60 level, awaiting its next move. Despite Monday’s rebound, the broader trend remains bearish, with the price trading below the 50-day and 200-day SMAs.

Additionally, the RSI remains below the midline, signalling continued downside momentum. A breakout above $62.50 would suggest further upside toward the 200-day SMA near $65. However, a breakdown below the $59 region could open the door to further declines toward $55.50.

WTI Oil 4-Hour Chart – Negative Price Action
The 4-hour chart for WTI crude oil shows the price consolidating below the $62 level, reflecting market uncertainty. As long as it remains below $62.50, the bias for oil prices stays bearish.

A break below the $59 region would signal further downside. On the other hand, a breakout above $62.50 could pave the way for the $65.50 level. The RSI on the 4-hour chart also remains in negative territory, reinforcing the potential for further downside.

Natural Gas (NG) Technical Analysis
Natural Gas Daily Chart – Bullish Momentum
The daily chart for natural gas (NG) shows that the price has broken above the $3.50 level, as indicated by the black trendline. The 50-day SMA is now crossing above the 200-day SMA near $3.50, signalling a bullish trend in natural gas prices.

A breakout above the $4.50 level would confirm further upside potential. However, a pullback toward the $3.50 level would offer a strong buying opportunity for the next leg higher.

The overall direction for natural gas remains bullish. However, the RSI indicates that prices have reached overbought territory, suggesting a potential short-term correction.

Natural Gas 4-Hour Chart – Positive Structure
The 4-hour chart for natural gas shows that the price has broken above the black dotted trendline, located around the $3.50–$3.60 level, and is moving toward $4.70. This breakout signals bullish price action in the short term.

A break above $4.70 would indicate further upside momentum. However, any correction in natural gas prices should be viewed as a buying opportunity for short-term traders.

US Dollar Index (DXY) Technical Analysis
US Dollar Daily Chart – 200 Day SMA
The daily chart for the US Dollar Index shows that it has been consolidating below the 200-day SMA near the 100.50 level. As long as the index remains below this level, the trend remains negative.

A break above 100.50 could push the index toward the 102 level. However, a break below 98.20 may trigger a drop toward 96.50. The RSI has reached the 70 level, indicating that a short-term correction may be likely.

US Dollar 4-Hour Chart – Negative Price Action
The 4-hour chart for the U.S. Dollar Index shows that the index has been consolidating between the 96.50 and 100.50 levels. The index has reached the upper end of its range at 100.50. It may now consolidate further in the short term and potentially move lower toward the 98.60 support level. A break above 100.50 will take the index towards the 102 level.

Related Articles

Natural Gas Price Forecast: Breakout Above $4.45 Tests Upper Channel ResistanceSilver (XAGUSD) Price Forecast: $50.56 14-Day High Recaptures 20-Day MAGold (XAUUSD), Silver, Platinum Forecasts – Gold Tests The $4100 LevelAbout the Author

Muhammad Umair is a finance MBA and engineering PhD. As a seasoned financial analyst specializing in currencies and precious metals, he combines his multidisciplinary academic background to deliver a data-driven, contrarian perspective. As founder of Gold Predictors, he leads a team providing advanced market analytics, quantitative research, and refined precious metals trading strategies.

Editors’ Picks

XRP News Today: Bullish Breakout Ahead of Canary XRP ETF Debut

Silver (XAGUSD) Price Forecast: $50.56 14-Day High Recaptures 20-Day MA

NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Rallies As Palantir Soars 9%

U.S. Dollar Gains Ground Amid Attempts To End The Shutdown: Analysis For EUR/USD, GBP/USD, USD/CAD, USD/JPY

Natural Gas Price Forecast: Breakout Above $4.45 Tests Upper Channel Resistance

Advertisement